PACIS 120 MG
BACILLUS CALMETTE-GUERIN (BCG) SUBSTRAIN MONTREAL : 120 MG · DIN 02130947 · ID BIOMEDICAL CORPORATION OF QUEBEC
Health Canada status: CANCELLED POST MARKET
What is PACIS?
PACIS 120 MG contains BACILLUS CALMETTE-GUERIN (BCG) SUBSTRAIN MONTREAL : 120 MG. It is listed in the Health Canada Drug Product Database under DIN 02130947, held by ID BIOMEDICAL CORPORATION OF QUEBEC, supplied as POWDER FOR SOLUTION for INTRAVESICULAR administration. Health Canada currently lists it as cancelled post market, status dated 02-Dec-2005. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02130947 |
|---|---|
| Brand name | PACIS |
| Generic / active ingredient | BACILLUS CALMETTE-GUERIN (BCG) SUBSTRAIN MONTREAL : 120 MG |
| Manufacturer | ID BIOMEDICAL CORPORATION OF QUEBEC |
| Strength | 120 MG |
| Dosage form | POWDER FOR SOLUTION |
| Route of administration | INTRAVESICULAR |
| Schedule | Prescription |
| ATC code | L03AX03 BCG VACCINE |
| AHFS class | 80:12.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 02-Dec-2005 |
| Original market date | 1994-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code L03AX03 BCG VACCINE. 2 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ONCOTICE | 800000000 UNIT | POWDER FOR SOLUTION | MERCK CANADA INC | MARKETED | DIN 02153513 |
| VERITY-BCG | 40 MG | POWDER FOR SUSPENSION | VERITY PHARMACEUTICALS INC. | MARKETED | DIN 02508613 |
| BCG THERAPEUTIC | 27 MG | POWDER FOR SOLUTION | CONNAUGHT LABORATORIES LTD. | CANCELLED POST MARKET | DIN 00884308 |
| IMMUCYST | 81 MG | POWDER FOR SUSPENSION | SANOFI PASTEUR LIMITED | CANCELLED POST MARKET | DIN 02194376 |
Who else supplies BCG VACCINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. BCG VACCINE appears in 12 registered pack listings across 5 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.